Role of Posterodorsal Medial Amygdala Urocortin-3 in Pubertal Timing in Female Mice.
MePD
Ucn3
behavior
puberty
stress
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2022
2022
Historique:
received:
09
03
2022
accepted:
14
04
2022
entrez:
3
6
2022
pubmed:
4
6
2022
medline:
7
6
2022
Statut:
epublish
Résumé
Post-traumatic stress disorder impedes pubertal development and disrupts pulsatile LH secretion in humans and rodents. The posterodorsal sub-nucleus of the medial amygdala (MePD) is an upstream modulator of the hypothalamic gonadotropin-releasing hormone (GnRH) pulse generator, pubertal timing, as well as emotional processing and anxiety. Psychosocial stress exposure alters neuronal activity within the MePD increasing the expression of Urocortin3 (Ucn3) and its receptor corticotropin-releasing factor type-2 receptor (CRFR2) while enhancing the inhibitory output from the MePD to key hypothalamic reproductive centres. We test the hypothesis that psychosocial stress, processed by the MePD, is relayed to the hypothalamic GnRH pulse generator to delay puberty in female mice. We exposed C57Bl6/J female mice to the predator odor, 2,4,5-Trimethylthiazole (TMT), during pubertal transition and examined the effect on pubertal timing, pre-pubertal LH pulses and anxiety-like behaviour. Subsequently, we virally infected Ucn3-cre-tdTomato female mice with stimulatory DREADDs targeting MePD Ucn3 neurons and determined the effect on pubertal timing and pre-pubertal LH pulse frequency. Exposure to TMT during pubertal development delayed puberty, suppressed pre-pubertal LH pulsatility and enhanced anxiety-like behaviour, while activation of MePD Ucn3 neurons reduced LH pulse frequency and delayed puberty. Early psychosocial stress exposure decreases GnRH pulse generator frequency delaying puberty while inducing anxiety-behaviour in female mice, an effect potentially involving Ucn3 neurons in the MePD.
Identifiants
pubmed: 35655799
doi: 10.3389/fendo.2022.893029
pmc: PMC9152449
doi:
Substances chimiques
Urocortins
0
Gonadotropin-Releasing Hormone
33515-09-2
Luteinizing Hormone
9002-67-9
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
893029Subventions
Organisme : Medical Research Council
ID : MR/N026063/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N022637/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/S000550/1
Pays : United Kingdom
Informations de copyright
Copyright © 2022 Ivanova, Li, Liu, McIntyre, Fernandes, Lass, Kong and O’Byrne.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Neurosci. 2014 Jun 25;34(26):8699-715
pubmed: 24966371
Endocrinology. 2011 Feb;152(2):545-55
pubmed: 21159851
Alcohol Clin Exp Res. 2008 Oct;32(10):1782-94
pubmed: 18652593
Transl Psychiatry. 2018 Feb 21;8(1):49
pubmed: 29463821
Psychoneuroendocrinology. 2015 Jan;51:307-17
pubmed: 25462903
J Neuroendocrinol. 2020 Feb;32(2):e12823
pubmed: 31872920
Endocrinology. 2006 Oct;147(10):4578-88
pubmed: 16809443
J Neuroendocrinol. 2018 Mar;30(3):e12572
pubmed: 29356147
Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):E10216-E10223
pubmed: 29109258
Endocrinology. 2005 Jan;146(1):318-22
pubmed: 15388651
J Am Acad Child Adolesc Psychiatry. 2016 Jan;55(1):25-32.e1
pubmed: 26703906
Endocrinology. 2015 Jun;156(6):2313-22
pubmed: 25856429
Adv Exp Med Biol. 2013;784:253-73
pubmed: 23550010
Elife. 2016 Aug 23;5:
pubmed: 27549338
JAMA Psychiatry. 2019 Sep 1;76(9):966-975
pubmed: 31141099
N Engl J Med. 2003 Oct 23;349(17):1614-27
pubmed: 14573733
Psychoneuroendocrinology. 2021 May;127:105154
pubmed: 33647571
Exp Neurol. 2016 Oct;284(Pt B):211-219
pubmed: 27283115
Nat Neurosci. 2016 Nov;19(11):1489-1496
pubmed: 27428651
Sci Rep. 2021 Jan 21;11(1):1996
pubmed: 33479437
Sci Rep. 2017 Apr 12;7:46381
pubmed: 28401948
Endocrinology. 2011 May;152(5):2020-30
pubmed: 21363930
Endocrinology. 2006 Feb;147(2):1007-13
pubmed: 16282350
Sci Rep. 2015 Jun 18;5:11208
pubmed: 26084728
Endocrinology. 2012 Oct;153(10):4883-93
pubmed: 22893725
PLoS One. 2017 Aug 28;12(8):e0183596
pubmed: 28846730
Endocrinology. 2017 Aug 1;158(8):2593-2602
pubmed: 28549157
J Physiol. 2004 Dec 1;561(Pt 2):379-86
pubmed: 15486019
Endocrinology. 2015 Oct;156(10):3725-36
pubmed: 26252061
J Neurosci. 2019 Dec 4;39(49):9738-9747
pubmed: 31645462
J Neurophysiol. 2015 Mar 1;113(5):1423-36
pubmed: 25475347
Neuroendocrinology. 2020;110(3-4):172-184
pubmed: 31466075
J Vis Exp. 2019 Aug 25;(150):
pubmed: 31498301
Nat Commun. 2019 May 30;10(1):2372
pubmed: 31147546
Ochsner J. 2008 Fall;8(3):129-33
pubmed: 21603464
Front Endocrinol (Lausanne). 2022 May 17;13:893029
pubmed: 35655799
Neuron. 2005 May 19;46(4):647-60
pubmed: 15944132
Front Neuroanat. 2012 Aug 21;6:33
pubmed: 22933993
PLoS One. 2019 Mar 27;14(3):e0213927
pubmed: 30917148
Pharmacol Biochem Behav. 1996 May;54(1):31-40
pubmed: 8728536
Endocrinology. 2021 Dec 1;162(12):
pubmed: 34618891
J Neurosci. 2002 Feb 1;22(3):991-1001
pubmed: 11826127
Am J Physiol. 1966 Nov;211(5):1103-7
pubmed: 5924030
Endocrinology. 2017 Nov 1;158(11):3716-3723
pubmed: 28973125
PLoS One. 2012;7(7):e39001
pubmed: 22802933
Endocrinology. 2013 Dec;154(12):4939-45
pubmed: 24092638
J Neuroendocrinol. 2009 Jan;21(1):20-9
pubmed: 19094090
Elife. 2021 Jan 19;10:
pubmed: 33464205
Brain Res. 2006 May 17;1089(1):116-25
pubmed: 16638605
Sci Rep. 2019 Oct 14;9(1):14768
pubmed: 31611573
J Neuroendocrinol. 2010 Feb;22(2):102-9
pubmed: 20002962
Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10972-6
pubmed: 12944565
Neuroscience. 2009 Aug 4;162(1):5-13
pubmed: 19358876
J Neurosci. 2010 Jul 7;30(27):9103-16
pubmed: 20610744
J Neuroendocrinol. 2019 Jun;31(6):e12719
pubmed: 30963653